Fiducient Advisors LLC Novo Nordisk A S Transaction History

Fiducient Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$95.28 - $116.93 $334,432 - $410,424	-3,510 Reduced 63.45%	2,022 $201,000
Q2 2022 Aug 04, 2022	BUY	$103.24 - $121.81 $362,372 - $427,553	3,510 Added 173.59%	5,532 $616,000
Q1 2022 May 09, 2022	SELL	$93.1 - $112.54 $8,006 - $9,678	-86 Reduced 4.08%	2,022 $227,000
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $184,281 - $225,027	-1,922 Reduced 47.69%	2,108 $236,000
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $6,706 - $7,581	-100 Reduced 2.42%	4,030 $272,000
Q4 2020 Feb 11, 2021	BUY	$63.89 - $73.8 $263,865 - $304,794	4,130 New	4,130 $288,000

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Fiducient Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Fiducient Advisors LLC with notifications on news.